RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Financials
  4. Cash from operations

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.5B
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024-390+31.68%
Dec 31, 2023-296-4.34%
Dec 31, 2022-309-1.47%
Dec 31, 2021-314+8.02%
Dec 31, 2020-291-21.55%
Dec 31, 2019-371+21.75%
Dec 31, 2018-304+6.73%
Dec 31, 2017-285-839.67%
Dec 31, 201639-150.11%
Dec 31, 2015-77+29.65%
Dec 31, 2014-59+5.24%
Dec 31, 2013-56

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)